跳至主要内容
临床试验/IRCT201012084010N4
IRCT201012084010N4已完成2 期

The effects of synbiotics supplement on lipid profile, liver enzymes, inflammatory factors and hepatic fibrosis in patients with Nonalcoholic Steatohepatitis

ational Nutrition and Food Technology Research Institute (NNFTRI)0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Age of 18 years and older; BMI between 25-40; Abnormal serum transferase (ALT & AST more than 1.5 fold of normal range); Sonographic findings compatible with hepatic steatosis (degree 2 or more). Exclusion criteria: Diabetes; Using antibiotic 2 weeks before recruitment to the study; A history of alcohol consumption; Pregnancy & Breast feeding, Professional athletes; Liver disease (viral/etc); Use of drugs such as calcium channel blockers, high dose synthetic estrogens, methotrexate , amiodarone, steroids, chloroquine, immunosuppressive drugs, lipid-lowering agents, metformin and vitamin E; A history of Hypertension, Cardiovascular disease, Pulmonary disease, Renal disease & Celiac disease; Cirrhosis; Medications causing NAS; Upper GI surgery / Prior surgical procedures such as jejunoileal or jejunocolic bypass, gastroplasty, following program to lose weight in recent 3 mo;-A history of hypothyroidism or Cushing’s syndrome.

排除标准

  • 未提供

研究者

发起方
ational Nutrition and Food Technology Research Institute (NNFTRI)

相似试验